The same Nasal spray that had the company scratching its head last year when saline out-performed the product during trials for a common cold remedy.
I doubt we'll see the same price rise for BOT, we know the product works whereas FRE was told it doesn't - not for it's intended purpose anyway. They don't need FDA approval for a "nasal hygiene spray" Smart work by the company.
BOT - Anything but charting, page-7937
-
- There are more pages in this discussion • 982 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |